1227382-01-5

Basic information

• Product Name: tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate oxalate
• Synonyms: tert-butyl 6-aza-2-azoniaspiro[3.3]heptane-6-carboxylate oxalate
• CAS NO: 1227382-01-5
• Molecular Formula: C₂H₂O₄*C₁₀H₁₈N₂O₂
• Molecular Weight: 288.297
• Mol File: 1227382-01-5.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate oxalate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate oxalate(1227382-01-5)
• EPA Substance Registry System: tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate oxalate(1227382-01-5)

Safety Data

• Hazardous Substances Data: 1227382-01-5(Hazardous Substances Data)

Usage

Description

tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate oxalate is a complex organic compound that belongs to the category of synthetic chemicals. It is characterized by a cyclic diazaspiro[3.3]heptane core, a tert-butyl group, a carboxylate ester, and an oxalate group, which together suggest a wide range of potential reactivity and applications in advanced fields such as pharmaceuticals or materials science.

Uses

Used in Pharmaceutical Industry:
tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate oxalate is used as a building block or intermediate in the synthesis of certain drugs or molecular compounds. Its unique structure and multiple functional groups allow for versatile reactivity, making it a valuable component in the development of new pharmaceuticals.
Used in Materials Science:
tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate oxalate is used as a component in the creation of novel materials with specific properties. Its complex structure and functional groups can contribute to the development of advanced materials with applications in various industries, such as electronics, coatings, or adhesives.
As with any chemical substance, appropriate caution should be used when handling or using tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate oxalate to ensure safety and effectiveness in its intended applications.

Upstream product

• 1150618-17-9 di-tert-butyl 2,6-diazaspiro[3.3]heptane-2,6-dicarboxylate 
• 144-62-7 oxalic acid 

Downstream Products

• 1333215-20-5 tert-butyl 6-(4-fluorophenyl)-2,6-diazaspiro[3,3]heptane-2-carboxylate 
• 1333215-19-2 2-(4-fluorophenyl)-2,6-diazaspiro[3,3]heptane 
• 1431868-56-2 6-(2,4-dichloro-benzylcarbamoyl)-2,6-diaza-spiro[3.3]heptane-2-carboxylic acid tert-butyl ester 
• 1431868-35-7 6-benzoyl-2,6-diaza-spiro[3.3]heptane-2-carboxylic acid 2,4-dichloro-benzylamide 
• 1431868-57-3 2,6-diaza-spiro[3.3]heptane-2-carboxylic acid 2,4-dichloro-benzylamide 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE

Heterocyclic compounds of structural formula I are inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD). The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease; atherosclerosis; obesity; diabetes; neurological disease; Metabolic Syndrome; insulin resistance; cancer, liver steatosis; and non-alcoholic steatohepatitis.